Clinical Trial Update: AO-176 in Multiple Solid Tumor Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for AO-176 in solid tumor malignancies completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AO-176

Snippet

Sponsor: Arch Oncology | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED